{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:55:06Z","timestamp":1775130906481,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.amjmed.2017.10.052","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T02:30:23Z","timestamp":1511404223000},"page":"222-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Which Patent Foramen Ovales Need Closure to Prevent Cryptogenic Strokes?"],"prefix":"10.1016","volume":"131","author":[{"given":"James E.","family":"Dalen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph S.","family":"Alpert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2017.10.052_bib0010","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM198805053181802","article-title":"Prevalence of patent foramen ovale in patients with stroke","volume":"318","author":"Lechat","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0015","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.CIR.0000017498.88393.44","article-title":"Effect of medical treatment in stroke patients with patent foramen ovale","volume":"105","author":"Homma","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.CIR.0000046073.34261.C1","article-title":"Contemporary management of patent foramen ovale","volume":"107","author":"Meier","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0025","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0002-9343(72)90171-4","article-title":"Paradoxical embolism: diagnosis during life","volume":"53","author":"Meister","year":"1972","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.amjmed.2010.07.022","article-title":"Patent foramen ovales and cryptogenic strokes: another look","volume":"124","author":"Dalen","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0035","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0040","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0045","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0050","doi-asserted-by":"crossref","first-page":"695","DOI":"10.7326\/0003-4819-105-5-695","article-title":"Clinically silent atrial septal defects with evidence for cerebral embolization","volume":"105","author":"Harvey","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0055","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1161\/01.CIR.86.6.1902","article-title":"Transcatheter closure of patent foramen ovale after presumed paradoxical embolism","volume":"86","author":"Bridges","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0060","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jacc.2003.10.030","article-title":"Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1,000 consecutive patients","volume":"43","author":"Krumsdorf","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0065","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0070","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0080","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"Sondergaard","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0075","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJMoa011503","article-title":"Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm or both","volume":"345","author":"Mas","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0085","first-page":"169","article-title":"Anevrysme de la cloison interauricrlaire revele par une embolie cerebrale","volume":"66","author":"Grosgogeat","year":"1973","journal-title":"Arch Mal Coeur"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0090","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/hrt.53.3.292","article-title":"Atrial septal aneurysm-a potential cause of systemic embolism","volume":"53","author":"Gallet","year":"1985","journal-title":"Br Heart J"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0095","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1161\/01.CIR.91.11.2785","article-title":"Atrial septal aneurysm in adult patients","volume":"91","author":"Mugge","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0100","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/01.WNL.0000119173.15878.F3","article-title":"Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm","volume":"62","author":"Messe","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0105","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/01.STR.18.5.856","article-title":"Atrial septal aneurysm: association with cerebrovascular and peripheral embolic events","volume":"18","author":"Belkin","year":"1987","journal-title":"Stroke"},{"key":"10.1016\/j.amjmed.2017.10.052_bib0110","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.amjmed.2006.03.021","article-title":"Are patients with a patent foramen ovale at increased risk of stroke? A billion dollar question","volume":"120","author":"Dalen","year":"2007","journal-title":"Am J Med"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934317311944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934317311944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:13:47Z","timestamp":1757582027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934317311944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0002934317311944"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2017.10.052","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Which Patent Foramen Ovales Need Closure to Prevent Cryptogenic Strokes?","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2017.10.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}